Prabir Roy Chaudhury, MD
Nephrology · Cincinnati, OHNPI 1255399721
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $130,117 of the $204,560 with a category attached, or 63.6%. 14 manufacturers reported payments, led by AstraZeneca at 45.0% of the total. Among nephrology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $1471.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$92K
- Bayer$28K
- W. L. Gore & Associates, Inc.$18K
- Chugai Pharmaceutical Co., Ltd.$16K
- Boston Scientific$11K
- Vifor Pharma, Inc.$11K
- plus $28K from 8 others
Across 48 payments — averaging $5902.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merit Medical Systems Inc$272K
- Bayer$6K
- Covidien LP$5K
What the payments were for
- Consulting fees$130,11764%
- Speaking & faculty fees$10,0455%
- Travel & lodging$59,90029%
- Food & beverage$4,4992%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 33 | $91,974 |
| Bayer | 39 | $28,457 |
| W. L. Gore & Associates, Inc. | 12 | $17,755 |
| Chugai Pharmaceutical Co., Ltd. | 4 | $16,182 |
| Boston Scientific | 8 | $11,495 |
| Vifor Pharma, Inc. | 11 | $11,105 |
| Medtronic | 14 | $10,347 |
| Akebia Therapeutics Inc | 1 | $7,000 |
| Mozarc Medical US LLC | 8 | $6,220 |
| Merck | 1 | $2,725 |
| BD | 4 | $1,069 |
| Amgen | 1 | $140 |
| Bard Peripheral Vascular, Inc. | 2 | $66 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$26,135
- Non-Covered Product$16,182
- VIABAHN Endoprosthesis$15,120
- Veltassa$11,008
- GENERAL - THERAPIES$10,096
- ULTOMIRIS$9,997
- AURYXIA$7,000
- Palindrome$5,966
- IN.PACT Admiral$5,638
- LOKELMA$3,112
- Non-Covered$1,600
- Product in Development$1,470
- ACUSEAL Vascular Graft$792
- IN.PACT AV$525
- GORE EXCLUDER AAA Endoprosthesis$173
- Tavneos$140
How this compares
$204,560 in reported general payments places this provider in the 95th percentile of 450 nephrology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Cincinnati
- Amit GovilCincinnati$298K
- Charuhas ThakarCincinnati$107K
- Chebel KhalilCincinnati$72K
- Arshdeep TindniCincinnati$41K
- Joseph KremerCincinnati$29K
- Tahir SajjadCincinnati$20K
- Silvi ShahCincinnati$14K
- Prakash GudsoorkarCincinnati$10K
- Ahmad AnjakCincinnati$9K
- Karl PembaurCincinnati$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.